Hemp & Health S.A. (WSE:HMP)
Poland · Delayed Price · Currency is PLN 0.2500
+0.0450 (21.95%)
At close: Jun 15, 2026
Hemp & Health Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 0.21 | 0.13 | 0.27 | 1.07 | 2.52 | |
Revenue Growth (YoY) | 63.14% | -52.78% | -74.69% | -57.43% | 1647.62% |
Cost of Revenue | 0.35 | 0.28 | 0.31 | 1.05 | 1.84 |
Gross Profit | -0.14 | -0.15 | -0.04 | 0.02 | 0.68 |
Selling, General & Admin | 1.16 | 0.87 | 0.64 | 0.75 | 0.59 |
Other Operating Expenses | 0.03 | 0.01 | 0.01 | -0.17 | 0.1 |
Operating Expenses | 1.29 | 0.94 | 0.69 | 0.57 | 0.69 |
Operating Income | -1.43 | -1.09 | -0.73 | -0.55 | -0.01 |
Interest Expense | - | - | -0 | -0.04 | -0.01 |
Interest & Investment Income | 0.12 | 0.19 | 0.1 | 0 | - |
Other Non Operating Income (Expenses) | -0.03 | -0.07 | -0.01 | -0 | -0.01 |
EBT Excluding Unusual Items | -1.35 | -0.98 | -0.63 | -0.58 | -0.03 |
Gain (Loss) on Sale of Investments | -0.04 | 0.01 | -0.21 | -2.33 | -0.19 |
Asset Writedown | -0 | -0.06 | - | - | -0.34 |
Pretax Income | -1.39 | -1.03 | -0.84 | -2.91 | -0.55 |
Earnings From Continuing Operations | -1.39 | -1.03 | -0.84 | -2.91 | -0.55 |
Net Income | -1.39 | -1.03 | -0.84 | -2.91 | -0.55 |
Net Income to Common | -1.39 | -1.03 | -0.84 | -2.91 | -0.55 |
Shares Outstanding (Basic) | - | 72 | 72 | 72 | 29 |
Shares Outstanding (Diluted) | - | 72 | 72 | 72 | 29 |
Shares Change (YoY) | - | - | - | 147.48% | - |
EPS (Basic) | - | -0.01 | -0.01 | -0.04 | -0.02 |
EPS (Diluted) | - | -0.01 | -0.01 | -0.04 | -0.02 |
Free Cash Flow | -1.54 | -1.78 | -0.84 | 0.04 | -0.85 |
Free Cash Flow Per Share | - | -0.03 | -0.01 | 0.00 | -0.03 |
Gross Margin | -68.46% | -118.73% | -15.25% | 2.27% | 27.00% |
Operating Margin | -685.81% | -850.80% | -267.99% | -51.28% | -0.42% |
Profit Margin | -664.60% | -802.48% | -310.56% | -271.33% | -21.89% |
Free Cash Flow Margin | -735.92% | -1385.00% | -308.63% | 3.51% | -33.87% |
EBITDA | -1.33 | -1.03 | -0.69 | - | - |
EBITDA Margin | - | - | -254.74% | - | - |
D&A For EBITDA | 0.1 | 0.06 | 0.04 | - | - |
EBIT | -1.43 | -1.09 | -0.73 | -0.55 | -0.01 |
EBIT Margin | - | - | -267.99% | -51.28% | -0.42% |
Revenue as Reported | 0.21 | 0.13 | 0.27 | 1.07 | 2.52 |